PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+12.33%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.81B
AUM Growth
+$1.81B
(+3.4%)
Cap. Flow
-$83.9M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
73.95%
Holding
42
New
–
Increased
9
Reduced
3
Closed
–
Top Buys
| 1 |
Biogen
BIIB
|
$6.37M |
| 2 |
Insmed
INSM
|
$5.54M |
| 3 |
eHealth
EHTH
|
$5.11M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$2.72M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$2.35M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$83.3M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$25.8M |
| 3 |
Prothena Corp
PRTA
|
$567K |
Sector Composition
| 1 | Healthcare | 95.6% |
| 2 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $193M | 10.65% | 1,267,811 -546,100 | -30% | -$83.3M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $185M | 10.18% | 2,212,950 +7,200 | +0.3% | +$601K |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $182M | 10.04% | 583,933 +8,700 | +2% | +$2.72M |
|
|
4
Insmed
INSM
$28.8B
| $171M | 9.44% | 6,019,106 +194,599 | +3% | +$5.54M |
|
|
5
Biogen
BIIB
$19.4B
| $125M | 6.9% | 361,600 +18,400 | +5% | +$6.37M |
|
6
United Therapeutics
UTHR
$13.8B
| $123M | 6.79% | 687,206 | – | – |
|
7
Amicus Therapeutics
FOLD
$2.34B
| $96.4M | 5.31% | 10,002,443 +241,400 | +2% | +$2.33M |
|
|
RVNC
8
DELISTED
Revance Therapeutics, Inc.
RVNC
| $94.9M | 5.23% | 3,201,866 | – | – |
|
|
9
Prothena Corp
PRTA
$441M
| $89M | 4.91% | 1,731,482 -11,023 | -0.6% | -$567K |
|
10
Vanda Pharmaceuticals
VNDA
$279M
| $81.6M | 4.49% | 3,791,805 | – | – |
|
|
11
eHealth
EHTH
$118M
| $66.9M | 3.69% | 1,145,870 +87,500 | +8% | +$5.11M |
|
12
Acadia Pharmaceuticals
ACAD
$4.38B
| $57M | 3.14% | 2,337,877 | – | – |
|
|
EPZM
13
DELISTED
Epizyme, Inc
EPZM
| $57M | 3.14% | 6,856,513 | – | – |
|
14
Karyopharm Therapeutics
KPTI
$61.7M
| $55.6M | 3.06% | 5,383,052 +19,400 | +0.4% | +$200K |
|
|
SAGE
15
DELISTED
Sage Therapeutics
SAGE
| $34.1M | 1.88% | 600,500 | – | – |
|
16
Align Technology
ALGN
$10.3B
| $33.9M | 1.87% | 55,405 | – | – |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $26M | 1.43% | 4,484,411 | – | – |
|
|
GRTS
18
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $21.5M | 1.19% | 2,356,282 +57,900 | +3% | +$529K |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $17.4M | 0.96% | 94,850 -140,426 | -60% | -$25.8M |
|
20
Gossamer Bio
GOSS
$562M
| $14.4M | 0.79% | 1,772,950 | – | – |
|
21
Puma Biotechnology
PBYI
$254M
| $12.8M | 0.7% | 1,392,997 | – | – |
|
|
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $12.4M | 0.68% | 332,713 | – | – |
|
23
Alkermes
ALKS
$4.78B
| $11.9M | 0.66% | 487,100 | – | – |
|
24
AnaptysBio
ANAB
$569M
| $11.3M | 0.62% | 436,592 | – | – |
|
|
25
Syndax Pharmaceuticals
SNDX
$1.41B
| $6.89M | 0.38% | 401,100 +136,900 | +52% | +$2.35M |
|